Fetal Bovine Serum (FBS) Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Denmark, China, India - Size and Forecast 2024-2028

Published: Dec 2023

Pages: 169

SKU: IRTNTR73855

Snapshot

Fetal Bovine Serum (FBS) Market 2024-2028

The Fetal Bovine Serum (FBS) Market size is estimated to grow by USD 294.16 million at a CAGR of 5.25% between 2023 and 2028.

A stem cell has several applications in research and the biopharmaceutical industry. The efficiency of cellular reprogramming for induced pluripotent stem cells contributes to its popularity. Furthermore, it contains a variety of tissue origins, making it better than others, such as human serum. Its numerous uses drive the growth of the FBS market as tissue development requires the use of FBS. Furthermore, FBS has advantages in serum cell culture, such as stem cell differentiation, morphology, cell proliferation and expansion, and clonal efficiency. Such factors are propelling the demand for FBS, which will drive the growth of the fetal bovine serum market during the forecast period

Technavio has segmented the market into Application, End-user, and Geography

The Application segment is classified into biopharmaceuticals, human and animal vaccine, and others
The End-user segment is classified into pharmaceutical and biopharmaceutical companies, contract research organization, and academic and research organization
The Geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018-2022, besides analyzing the current market scenario.

What will be the Size of the Fetal Bovine Serum Market During the Forecast Period?

To learn more about this report, Download Report Sample

Fetal Bovine Serum Market Segmentation by Application, End-user and Geography Analysis

Application Analysis

Biopharmaceuticals

The market share growth by the biopharmaceuticals segment will be significant during the forecast period. This is due to the increase in the adoption of biopharmaceutical drugs and the increase in the prevalence of chronic diseases such as cancer, arthritis, and cardiovascular disease across the globe, which is expected to drive growth in the fetal bovine serum (FBS) market during the forecast period.

Get a glance at the market contribution of various segments Download PDF Sample

The biopharmaceuticals were the largest segment and were valued at USD 333.71 million in 2018. Biopharmaceutical drugs have transformed the treatment of a wide range of diseases and are now utilized in practically every field of medicine. The biopharmaceuticals market has grown significantly faster than the overall drug market in recent years, and given the high demand for these medications, it is thought to have significant room for future dynamic expansion.FBS, which contains altered active pharmaceutical ingredients with enhanced efficacy, will play a vital role in the development of biopharmaceuticals. This review highlights recent progress in the field of biopharmaceutical development and issues regarding the registration of innovative biopharmaceutical medicines. Such factors are expected to fuel the growth of the biopharmaceuticals segment which fosters the growth of global fetal bovine serum during the forecast period.

End-user Analysis

Pharmaceutical and biopharmaceutical companies

The development and manufacturing of pharmaceuticals and biopharmaceuticals companies depend heavily on fetal bovine serum (FBS), which supports cell culture techniques that are necessary for pre-clinical testing, research, and manufacturing procedures. However, ongoing research and development of substitute technologies and sustainable sourcing methods are required due to the ethical issues and limitations of FBS. Pharmaceutical and biopharmaceutical companies can guarantee access to high-quality FBS and push the boundaries of medicine for the benefit of patients globally by working with reputable FBS vendors and investigating alternatives. Thus, the above-mentioned factors drive the pharmaceuticals and biopharmaceutical companies segment, which in turn boosts the growth of the global fetal bovine serum market during the forecast period.

Contract research organization

Contract research organizations (CROs), which offer services to pharmaceutical and biopharmaceutical companies, are essential to drug development and discovery. FBS is essential to the provision of several CRO services, such as: Pre-clinical Drug Testing: To facilitate the testing of possible medication candidates in cell culture models, contract research organizations (CROs) use fetal bovine serum, which enables them to assess a drugs toxicity, safety, and efficacy prior to clinical trials. Clinical trials are required for all new drugs and most imported drug registrations. In China, trials are also necessary for all generic biological products and certain generic drug applications. This will further increase the demand for the contract research organization segment, which, in turn, boost the growth of the fetal bovine serum market during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. The fetal bovine serum (FBS) market in North America is expected to have a steady growth rate during the forecast period, mainly due to the growth of the pharmaceutical industry in the region. Factors such as rising investment by the government, a rise in the number of clinical diagnostics businesses, and the growing focus on developing biopharmaceuticals are promoting the growth of the fetal bovine serum (FBS) market in North America. The federal government in the US is playing an important role in supporting R&D efforts, leading to scientific breakthroughs and new technologies in the development of FBS. Furthermore, there has been an ongoing trend of mergers and acquisitions (M&A) among the companies in the fetal bovine serum market.

For instance, in December 2021, Thermo Fisher Scientific Inc. announced its complete acquisition of PPD Inc. for USD 17.4 billion to expand its market reach. The growing competition among vendors has increased the number of M&A activities over the past few years. With the increasing demand for FBS from various end-users such as biopharma, biotech medical, pharmaceutical, and others, vendors are opting for M&A activities and strategic alliances to expand their market reach and customer base. Such factors will increase the market growth in this region during the forecast period.

Buy Full Report Now

Key Fetal Bovine Serum Market Players

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Animal Technologies Inc. - The company offers fetal bovine serum such as fetus torso, fetus, and fetus torso with organs.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Fetal Bovine Serum Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges.

Key Fetal Bovine Serum Market Drivers

Rising adoption of stem cell applications is notably driving the market growth. A stem cell has several uses in research and the biopharmaceutical industry. The efficiency of cellular reprogramming for induced pluripotent stem cells contributes to its popularity. Furthermore, it contains a variety of tissue origins, making it better than others, such as human serum. Its numerous uses drive the growth of the fetal bovine serum market as tissue development requires the use of FBS.

Furthermore, FBS has advantages in serum cell culture, such as stem cell differentiation, morphology, cell proliferation and expansion, and clonal efficiency. Such factors are propelling the demand for the FBS, which will drive the growth of the global fetal bovine serum market during the forecast period.

Significant Fetal Bovine Serum Market Trends

Increased focus on disease management is an emerging trend shaping the market growth. Cattle are susceptible to various diseases, some of which can have significant economic and health impacts on the livestock industry. Effective veterinary treatment systems are essential for the diagnosis, treatment, and prevention of these diseases, which can affect not only individual animals but also entire herds. Effective disease management in cattle involves both preventive measures, such as vaccination and biosecurity, and control measures to treat and manage diseases when they occur.

Moroever, disease management leads to healthier cattle herds. Healthy animals are more productive, have better growth rates, and produce higher-quality meat or dairy products. Farmers have a vested interest in maintaining the health of their cattle, which drives the demand for effective treatment systems, which is expected to have a positive impact on fetal bovine serum market growth. Such factors are expected to drive the market growth during the forecast period.

Major Fetal Bovine Serum Market Challenges

Regularity hurdle associated with animal drug development is a significant challenge hindering the market growth. Animal healthcare drugs have to go through a rigorous approval process conducted by regulatory agencies, such as the US Food and Drug Administration (FDA). This process involves extensive testing to demonstrate safety and efficacy. Manufacturers of animal healthcare drugs need to adhere to good manufacturing practices (GMP) standards to ensure the quality, safety, and consistency of their products. Regulations often require reporting of adverse events associated with the use of animal drugs. This helps monitor safety and identify potential issues.

Moreover, these regulations are intended to ensure that animal drugs are developed and manufactured to high standards of safety, efficacy, and quality. Compliance with these regulations is crucial for the responsible development, approval, and use of medications in animal healthcare. Thus, stringent regulation on drug development will hamper the growth of the fetal bovine serum market during the forecast period.

Buy Now Full Report

Key Fetal Bovine Serum Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Fetal Bovine Serum Market Customer Landscape

Segment Overview

The fetal bovine serum market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028.

Application Outlook
- Biopharmaceuticals
- Human and animal vaccine
- Others

End-user Outlook
- Pharmaceutical and biopharmaceutical companies
- Contract research organization
- Academic and research organization

Region Outlook
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- Rest of World (ROW)
  - Brazil
  - Argentina
  - Australia

Fetal Bovine Serum Market Scope
Report Coverage	Details
Page number	169
Base year	2023
Historic period	2018-2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 5.25%
Market growth 2024-2028	USD 294.16 million
Market structure	Fragmented
YoY growth 2023-2024(%)	4.97
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 38%
Key countries	US, Canada, Denmark, China, and India
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	Animal Technologies Inc., Atlas Biologicals Inc., Bio Techne Corp., Corning Inc., Danaher Corp., GeminiBio, GeneTex Inc., Grifols SA, HiMedia Laboratories Pvt. Ltd., Itoham Yonekyu Holdings Inc., Merck KGaA, MP Biomedicals Inc., Nucleus Biologics, PAN Biotech, Rocky Mountain Biologicals, Sartorius AG, TCS Biosciences Ltd., Thermo Fisher Scientific Inc., Tissue Culture Biologicals, and Celtic Molecular Diagnostics
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Fetal Bovine Serum Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the fetal bovine serum market between 2024 and 2028
Precise estimation of the fetal bovine serum market size and its contribution of the market in focus to the parent market
Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
Companies landscape comparing criticality of inputs and factors of differentiation
Exclusive Matrix on companies position and classification
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
Thorough analysis of the market’s competitive landscape and detailed information about companies
Comprehensive analysis of factors that will challenge the growth of fetal bovine serum market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global fetal bovine serum market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global fetal bovine serum market 2018 - 2022 ($ million)

4.2 Application Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ million)

4.3 End-user Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ million)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Application - Market share 2023-2028 (%)

6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application

6.3 Biopharmaceuticals - Market size and forecast 2023-2028
- Exhibit 34: Chart on Biopharmaceuticals - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Biopharmaceuticals - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Biopharmaceuticals - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Biopharmaceuticals - Year-over-year growth 2023-2028 (%)

6.4 Human and animal vaccine - Market size and forecast 2023-2028
- Exhibit 38: Chart on Human and animal vaccine - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Human and animal vaccine - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Human and animal vaccine - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Human and animal vaccine - Year-over-year growth 2023-2028 (%)

6.5 Others - Market size and forecast 2023-2028
- Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ million)
- Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)

6.6 Market opportunity by Application
- Exhibit 46: Market opportunity by Application ($ million)
- Exhibit 47: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by End-user

7.1 Market segments
- Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
- Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)

7.2 Comparison by End-user
- Exhibit 50: Chart on Comparison by End-user
- Exhibit 51: Data Table on Comparison by End-user

7.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028
- Exhibit 52: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)

7.4 Contract research organization - Market size and forecast 2023-2028
- Exhibit 56: Chart on Contract research organization - Market size and forecast 2023-2028 ($ million)
- Exhibit 57: Data Table on Contract research organization - Market size and forecast 2023-2028 ($ million)
- Exhibit 58: Chart on Contract research organization - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Contract research organization - Year-over-year growth 2023-2028 (%)

7.5 Academic and research organization - Market size and forecast 2023-2028
- Exhibit 60: Chart on Academic and research organization - Market size and forecast 2023-2028 ($ million)
- Exhibit 61: Data Table on Academic and research organization - Market size and forecast 2023-2028 ($ million)
- Exhibit 62: Chart on Academic and research organization - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Academic and research organization - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by End-user
- Exhibit 64: Market opportunity by End-user ($ million)
- Exhibit 65: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 67: Chart on Market share by geography 2023-2028 (%)
- Exhibit 68: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 69: Chart on Geographic comparison
- Exhibit 70: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Denmark - Market size and forecast 2023-2028
- Exhibit 91: Chart on Denmark - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on Denmark - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on Denmark - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Denmark - Year-over-year growth 2023-2028 (%)

9.9 China - Market size and forecast 2023-2028
- Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)

9.10 Canada - Market size and forecast 2023-2028
- Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.11 India - Market size and forecast 2023-2028
- Exhibit 103: Chart on India - Market size and forecast 2023-2028 ($ million)
- Exhibit 104: Data Table on India - Market size and forecast 2023-2028 ($ million)
- Exhibit 105: Chart on India - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on India - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 107: Market opportunity by geography ($ million)
- Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 109: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 110: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 111: Overview on factors of disruption

11.4 Industry risks
- Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 113: Vendors covered

12.2 Market positioning of vendors
- Exhibit 114: Matrix on vendor position and classification

12.3 Animal Technologies Inc.
- Exhibit 115: Animal Technologies Inc. - Overview
- Exhibit 116: Animal Technologies Inc. - Product / Service
- Exhibit 117: Animal Technologies Inc. - Key offerings

12.4 Atlas Biologicals Inc.
- Exhibit 118: Atlas Biologicals Inc. - Overview
- Exhibit 119: Atlas Biologicals Inc. - Product / Service
- Exhibit 120: Atlas Biologicals Inc. - Key offerings

12.5 Bio Techne Corp.
- Exhibit 121: Bio Techne Corp. - Overview
- Exhibit 122: Bio Techne Corp. - Business segments
- Exhibit 123: Bio Techne Corp. - Key offerings
- Exhibit 124: Bio Techne Corp. - Segment focus

12.6 Corning Inc.
- Exhibit 125: Corning Inc. - Overview
- Exhibit 126: Corning Inc. - Business segments
- Exhibit 127: Corning Inc. - Key news
- Exhibit 128: Corning Inc. - Key offerings
- Exhibit 129: Corning Inc. - Segment focus

12.7 Danaher Corp.
- Exhibit 130: Danaher Corp. - Overview
- Exhibit 131: Danaher Corp. - Business segments
- Exhibit 132: Danaher Corp. - Key news
- Exhibit 133: Danaher Corp. - Key offerings
- Exhibit 134: Danaher Corp. - Segment focus

12.8 Grifols SA
- Exhibit 135: Grifols SA - Overview
- Exhibit 136: Grifols SA - Business segments
- Exhibit 137: Grifols SA - Key offerings
- Exhibit 138: Grifols SA - Segment focus

12.9 HiMedia Laboratories Pvt. Ltd.
- Exhibit 139: HiMedia Laboratories Pvt. Ltd. - Overview
- Exhibit 140: HiMedia Laboratories Pvt. Ltd. - Product / Service
- Exhibit 141: HiMedia Laboratories Pvt. Ltd. - Key offerings

12.10 Itoham Yonekyu Holdings Inc.
- Exhibit 142: Itoham Yonekyu Holdings Inc. - Overview
- Exhibit 143: Itoham Yonekyu Holdings Inc. - Business segments
- Exhibit 144: Itoham Yonekyu Holdings Inc. - Key offerings
- Exhibit 145: Itoham Yonekyu Holdings Inc. - Segment focus

12.11 Merck KGaA
- Exhibit 146: Merck KGaA - Overview
- Exhibit 147: Merck KGaA - Business segments
- Exhibit 148: Merck KGaA - Key news
- Exhibit 149: Merck KGaA - Key offerings
- Exhibit 150: Merck KGaA - Segment focus

12.12 PAN Biotech
- Exhibit 151: PAN Biotech - Overview
- Exhibit 152: PAN Biotech - Product / Service
- Exhibit 153: PAN Biotech - Key offerings

12.13 Rocky Mountain Biologicals
- Exhibit 154: Rocky Mountain Biologicals - Overview
- Exhibit 155: Rocky Mountain Biologicals - Product / Service
- Exhibit 156: Rocky Mountain Biologicals - Key offerings

12.14 Sartorius AG
- Exhibit 157: Sartorius AG - Overview
- Exhibit 158: Sartorius AG - Business segments
- Exhibit 159: Sartorius AG - Key news
- Exhibit 160: Sartorius AG - Key offerings
- Exhibit 161: Sartorius AG - Segment focus

12.15 TCS Biosciences Ltd.
- Exhibit 162: TCS Biosciences Ltd. - Overview
- Exhibit 163: TCS Biosciences Ltd. - Product / Service
- Exhibit 164: TCS Biosciences Ltd. - Key offerings

12.16 Thermo Fisher Scientific Inc.
- Exhibit 165: Thermo Fisher Scientific Inc. - Overview
- Exhibit 166: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 167: Thermo Fisher Scientific Inc. - Key news
- Exhibit 168: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 169: Thermo Fisher Scientific Inc. - Segment focus

12.17 Tissue Culture Biologicals
- Exhibit 170: Tissue Culture Biologicals - Overview
- Exhibit 171: Tissue Culture Biologicals - Product / Service
- Exhibit 172: Tissue Culture Biologicals - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 173: Inclusions checklist
- Exhibit 174: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 175: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 176: Research methodology
- Exhibit 177: Validation techniques employed for market sizing
- Exhibit 178: Information sources

13.5 List of abbreviations
- Exhibit 179: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

fetal bovine serum market market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis